Summary
Cerebral cortical Lewy bodies occur in a spectrum of clinical syndromes including Parkinson’s disease (PD) with and without dementia, and dementing conditions clinically resembling Alzheimer’s disease with few or without parkinsonian features. It is unclear whether these conditions are variants of one disease process or represent pathogenetically distinct entities. Here we compared the cortical pathology in post mortem brains of three groups representing the predominant clinical phenotypes of Lewy body disease, including 27 non-demented cases of PD, 23 demented PD cases, and 11 cases of Lewy body disease who initially presented with dementia and showed only limited features of parkinsonism during the course of their illness. In addition to neuropathology, computer-assisted histoblot analysis was used to assess cortical amyloid ß-peptide deposition. There was wide overlap of the pathomorphometric features between the two groups of demented cases. It appears that substantial cortical Alzheimer-type pathology present in most demented cases contributes significantly to the development of dementia in Lewy body disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd ed, rev. American Psychiatric Association, Washington DC.
Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ (1994) Apolipoprotein E gene in Parkinson’s disease with and without dementia. Lancet 344: 889.
Benjamin R, Leake A, Edwardson JA, McKeith IG, Ince PG, Perry RH, Morris CM (1994) Apolipoprotein E genes in Lewy body and Parkinson’s disease. Lancet 343: 1565.
Flood JF, Roberts E, Sherman MA, Kaplan BE, Morley JE (1994) Topography of a binding site for small amnestic peptides deduced frosm structure-activity studies: relation to amnestic effect of amyloid ß protein. Proc Natl Acad Sci USA 91: 380–384.
Gibb WRG, Esiri MM, Lees AJ (1985) Clinical and pathological features of diffuse Lewy body disease (Lewy body dementia). Brain 110: 1131–1153.
Hansen LA, Galasko D (1992) Lewy body disease. Curr Opin Neuro Neurosurg 5: 889–894.
Hansen LA, Salmon D, Galasko D, Masliah E, Katzman R, Deteresa R, Thal L, Pay MM, Hofstetter R, Klauber M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer’s disease: a clinical and pathological entity. Neurology 40: 1–8.
Jendroska K, Lees AJ, Poewe W, Daniel SE (1994) Amyloid ß-peptide and its relationship with dementia in Parkinson’s disease. In: Korczyn AD (ed) Dementia in Parkinson’s disease. Monduzzi Editore, Bologna, pp 71–78.
Jendroska K, Poewe W, Daniel SE, Pluess J, Iwersen-Schmidt H, Paulsen J, Barthel S, Schelosky L, Cervós-Navarro J, DeArmond SJ (1995) Ischemic stress induces deposition of amyloid ß-immunoreactivity in human brain. Acta Neuropathol 90: 461–466.
Kosaka K (1990) Diffuse Lewy body disease in Japan. J Neurol 237: 197–204.
Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski HM (1995) Cell death in Alzheimer’s disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89: 35–41.
Lennox G (1992) Lewy body dementia. Ballieres Clin Neurol 1: 653–676.
Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by ß-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90: 7951–7955.
Mahler ME, Cummings JL (1990) Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis Assoc Disord 4: 133–149.
McKhann G, Grachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 34: 939–44.
Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK (1990) Senile dementia of Lewy body type: a clinical and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119–139.
Taraboulos A, Jendroska K, Serban D, Yang SL, DeArmond SJ, Prusiner SB (1992) Regional mapping of prion proteins in brain. Proc Natl Acad Sci USA 89: 7620–7624.
Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid ß protein: reversal by tachykinin neuropeptides. Science 250: 279–282.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag/Wien
About this paper
Cite this paper
Jendroska, K., Kashiwagi, M., Sassoon, J., Daniel, S.E. (1997). Amyloid ß-peptide and its relationship with dementia in Lewy body disease. In: Daniel, S.E., Cruz-Sánchez, F.F., Lees, A.J. (eds) Dementia in Parkinsonism. Journal of Neural Transmission. Supplementa, vol 51. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6846-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6846-2_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82959-2
Online ISBN: 978-3-7091-6846-2
eBook Packages: Springer Book Archive